DCA As a Glycolitic Inhibitor

August 17, 2014

DCA As a Glycolitic Inhibitor Helps In Fighting Cancer

DCA The oncologist will tell you that finding a treatment that is effective in killing the cancer cells while safe on the healthy body cells was the biggest problem in the field of oncology. The cancerous cells just as much as the healthy cells need nutrients to continue living. The oncologists plus other medical researchers have noted that the best way to treat cancer without affecting the healthy body cells is to deny them the nutrients supplies so that they can be starved to death. The cancer cells and the body cells require glucose from which they can make the ATP energy that they need to survive on. This made it hard to deny the cancer cells their nutrient supplies while leaving the healthy body cells nutrient supply unaffected. But this was in the past. Cancer researchers have found some existing differences between the survival mechanisms of the cancerous cells and the healthy body cells. Otto Warburg discovered that the cancerous cells depended entirely on the glucose to survive without which it could not live while the healthy body cells could make other sources of energy and continue living even when the sugar sources of energy were withdrawn. This discovery has led to more selective killing of the cancer cells without affecting the living body cells. The cancerous cells undergo increased glycolysis and rely on this pathway for generation of ATP energy as their sole source of energy for growth and survival but the healthy body cells are flexible to switch to other sources like fats.

Since the discovery by Warburg, oncologists have come up with different cancer therapies to help in killing the cancer cells effectively without hurting the healthy body cells. Overdependence of the cancer cell on the glycolitic pathway for generation of ATP energy as the sole source of survival has provided a great loophole through which the cancer cells can be selectively killed without affecting any other healthy cell by inhibiting glycolysis. To do this, glycolitic inhibitors must be used in order to weaken the cancer cells by blocking their nutrient supplies which is an anticancer itself thereby killing the cancer cells more effectively.

Cancer cells are characterized by increased glycolysis therefore when glycolitic inhibitors are used the cancer cells have no other ways of survival therefore they will die out of starvation. This approach has also been applauded in killing of cancer cells with mitochondrial defects that have become resistant to chemotherapy and radiation therapy drugs.

It may not be easy to understand the molecular and biochemical mechanisms that lead to increased aerobic glycolysis in the cancer cells, the metabolic repercussions of this increased glycolysis is very clear. The malignant cells become dependent or other addicted to the glycolysis pathway as the sole source of ATP energy. Researchers opine that the increased glycolysis in cancer cells may be caused by such factors as; hypoxia, oncogenic signals as well as mitochondrial dysfunction.

It is a known fact that the cancer cells need more energy to survive than the healthy cells. In glycolysis the ATP produced per glucose are only 2 which means the cancerous cells must use lots of glucose to survive unlike in the oxidative phosphorylation which generates more ATP energy per glucose the . Here 36 ATP are produced per glucose therefore small amount of glucose is needed for survival. So without glycolitic pathways the cancer cells are doomed.

In case of is glycolytic inhibition the healthy body cells will be able to adapt to other metabolic pathways to generate the ATP energy through the TCA cycle and oxidative phosphorylation in the mitochondria. The cancer cells however cannot adapt to other sources of ATP hence will die as they will not be able to live without another source of ATP energy. The healthy body cells will be able to adapt to new sources of energy like fatty acids and amino acids to produce metabolic intermediates channeled to the TCA cycle for ATP production through respiration. Glycolysis inhibition is therefore a clever way of killing the cancer cells without harm on the healthy body cells.

DCA is an effective glycolytic inhibitor

DCA works in very interesting ways in inhibiting glycolysis. It only leaves one option left for cancer cells to survive on- depending on other pathways as opposed to glycolysis. The cancer cells cannot do that hence they are killed. The healthy body cells can adapt to metabolic changes unlike the cancerous cells. The first way through which the body cells get energy is through glucose oxidation which happens in the mitochondria of every cell in the body and requires oxygen. Glucose respiration is the mostly utilized form of metabolism in the healthy cells. However in absence of oxygen the cells turn to glycolysis which takes place in the cell cytoplasm for energy generation. Glycolysis does not avail adequate ATP energy for normal cells; however it is the best for cancer cells. Glycolysis depends on sugar. This gives the healthy cell advantage as they have a backup plan in case the oxygen supply is interrupted. However to oxidize glucose there must be pyruvate. Pyruvate entry into the mitochondria is inhibited by an enzyme known as pyruvate dehydrogenase kinase (PDK). In case the PDK is strong then it will limit the transportation of pyruvate into the mitochondria and the healthy cells will have to depend on glycolysis even in presence of oxygen but incase its weak the pyruvate will be transported with ease to mitochondria even when the oxygen is low.

DCA Cancer cells have the most active PDK than the healthy cells and they are adapted to glycolysis. When PDK is weak then the cancer cells are disadvantaged and this is what the DCA does. It weakens PDK forcing the cancer cells to rely on glucose oxidation which does not favor them. Hence they will starve and die.

Dr. Dalal Akoury (MD) is an experienced integrative cancer doctor that has helped many cancer patients in their fight against the disease. She has worked hard not only in treating the disease but also in availing informational support to cancer patients at Awaremed which has become a place called home for many cancer patients. Call on her now and get help on cancer.

DCA As a Glycolitic Inhibitor Helps In Fighting Cancer

Polysubstance Abuse, You can fight Polysubstance Abuse

August 15, 2014

Fighting Polysubstance Abuse – Drug Addiction

Fighting polysubstance abuse- the war on drugs must be worn at all cost. Indulgence in polysubstance abuse is not helping fight the war.

We are living in a world where people want to explore all things even those things that are dangerous to their lives. Take for example drugs, there are substances which are not just harmful to one’s life but are life threatening and fatal. You would therefore wonder why someone would want to take this kind of adventure. I am not trying to confuse you here but I am talking about what is known as polysubstance abuse which is defined as the use of more than three groups of addictive substances over a period of one year. This normally happens when a person indulges in acts of abusing several substances within a short period of time, often in an attempt to enhance the effect of a single drug to create a more intense high. We can therefore conclude that polysubstance abuse is where no single substance is identified as the user’s drug of choice.

Some combination drug users have “patterned” use. These include:

Alcoholics who for example use will cocaine only after they’ve reached a certain state of intoxication meaning that they don’t overuse.
Addicts who speed ball that is to say that they are mixing cocaine and heroin for intravenous use and other combinations.
There is another polysubstance subgroup, consisting mostly of adults already addicted to alcohol. After an injury or surgery, they were placed on opiate medications and developed a pain syndrome over time. They then mixed substances or switched to opiates as their drug of choice.

Polysubstance Abuse among Different Populations

Adult polysubstance abuse, according to literature, is often associated with other mental health conditions. Homelessness, personality disorders, and psychiatric disorders such as major depression, psychosis, and bipolar disorder are common. The overlap of polysubstance dependence and psychiatric problems points to a lot of self-medication. Typically, among multiple substance users, individuals used alcohol or marijuana at an early age and then added other substances (or changed their drugs of choice) without quitting their original substances.

Among young people, polysubstance abuse is often the norm, and not the exception. The most commonly abused polysubstance by adolescents are marijuana, alcohol, and heroin. Other drugs used include MDMA (ecstasy), dextromethorphan, multiple forms of opiates, cocaine, hallucinogens, and inhalants.
A 2004 study of young people reported that one-half had used an illicit street drug by the end of their senior year. Two million young people need treatment for alcohol and drug addiction, but only 8 percent actually get it. Nearly one-third of young people addicted to psycho-stimulants also suffered from attention deficit hyperactivity disorder (ADHD), and 20 percent said they gave their medications to others.
One treatment facility said that 33 percent of the adolescents currently in treatment had polysubstance addiction.
The elderly are another population that clearly has a problem with polysubstance abuse.
Older people have more medical conditions that often require prescriptions. Over time with debilitating illnesses such as Alzheimer’s disease the tendency to over medicate (taking more of a drug, more often, forgetting when and if medication was already taken) increases the likelihood of polysubstance abuse. Combined with alcohol, the results can be devastating, even fatal.
Elderly women tend to keep their substance abuse and chemical dependency secret. Alcoholism occurs later in women’s lives, perhaps due to problems associated with divorce or separation. Women who are over 55 have less tolerance for alcohol and are therefore more prone to addiction. They are also less likely than men to seek treatment and also use prescribed psychoactive drugs.
Polysubstance abuse is increasingly prevalent among the street drug user population. Different substances abused include heroin, prescription opioids, benzodiazepines, cocaine, crack, alcohol, and marijuana.

Detoxification for Polysubstance Abuse and Addiction

Before treatment to address underlying causes of polysubstance addiction, detoxification must first be done. Detox is more complex and problematic with polysubstance addiction for several reasons. An accurate history of total substances abused must be obtained, and the patient may not be able or willing to provide complete details. Determination of the actual substance being used has to be made using screens for breath, urine, and/or blood.

Some patients can be treated on an outpatient basis, but others, particularly those with alcohol, sedative, hypnotic, opioid, and anxiolytic abuse may require hospitalization or inpatient detox. Repeated abstinence failures or severe anxiety, depression, or psychotic symptoms lasting 1 to 3 days after abstinence may also require inpatient substance abuse treatment.
After patients admitted for detox for opioids began to show classic alcohol withdrawal symptoms, some treatment professionals opted to routinely treat their detox patients with thiamine until a determination could be made that there was no history of alcohol use.
Diagnosis and treatment of patients who have been on psychotropic medications while they were already addicted is more difficult.
If a patient doesn’t know, or is unable to discuss, use of opioid drugs and it’s been days since their last drug use, opiate withdrawal symptoms can lag. Urine screens my not be able to detect the drug.
Treatment for mixed addiction that also includes alcohol use may include benzodiazepines during the acute phase of alcohol withdrawal. Benzodiazepines can help decrease tremors and prevent or reduce increases in heart rate and blood pressure.
Medication to treat symptoms of diarrhea or muscle aches may also be prescribed. Folic acid, thiamine, and Vitamin B-12 may counteract vitamin deficiencies.

Evaluation Factors

The length of the treatment program is determined by how long and what type of substance dependence the patient has, whether or not organ damage exists, any underlying mental illness, the patient’s desire to change and willingness to undergo treatment, adequacy of the patient’s social support system, treatment choice, and plans for ongoing care.

Treatment after Detox

After drug use patterns and substances have been identified, a thorough psychological evaluation is necessary. There needs to be enough time for detox, history evaluation, and a thorough understanding of any psychiatric conditions that exist.

Although there are many different aspects of treatment, they generally include four phases.

The acute phase – this is where the focus is on alleviating symptoms or physiological withdrawal. This typically lasts 3 to 5 days, but is dependent on the number, type, and length of substances abused.

The abstinence period – this phase concentrates on changing the patient’s behavior which is usually about one month

The early remission phase – follows and can last up to 12 months. The sustained remission phase lasts as long as the patient refrains from alcohol or substance use and no longer exhibits any of the criteria for polysubstance abuse.

Treatment during early remission may involve education on the physical, emotional, and psychological aspects of addiction and recovery. The patient learns to identify stressors and triggers that cause drug use. They learn ways to manage those stressors and also build up coping skills. They can also undergo assertiveness training and relaxation techniques.

Polysubstance Addiction – Is There Hope?

Fighting polysubstance abuse is more difficult than abuse of a single substance, but it can be successful. The likelihood of success depends on the individual’s determination and discipline to follow through on the requirements to abstain completely from substance abuse. Such determination and discipline does not come easily, especially for hard-core or long-term abusers and addicts. There may be repeated relapses before stability becomes a part of the recovering addict’s life. After treatment, recovery from polysubstance abuse and addiction just like for any addiction requires ongoing diligence and participation in a support network. While understanding the difficulty involved in treatment and recovery of this nature doctor Dalal Akoury established AWAREmed Health and Wellness Resource Center facility to help in the treatment of all kinds of addiction. Doctor Akoury cares for you and she is riding on more than two decades of experience. Calling on doctor Akoury will benefits you since she will attend to you in the most natural way by focusing on Neuroendocrine Restoration (NER) to reinstate normality through realization of the oneness of Spirit, Mind, and Body, Unifying the threesome into ONE

Fighting Polysubstance Abuse – Drug Addiction

Aromatase Inhibitors and Cancer

August 15, 2014

Aromatase Inhibitors Are Effective In Fighting Cancer

Aromatase inhibitors may help in fighting cancer as they stop a key enzyme called aromatase from changing other hormones into estrogen. It works differently from other drugs that focus on blocking the oxygen receptors such as tamoxifen and raloxifene. This helps in lowering the levels of the estrogen hormone in the body denying the estrogen receptor-positive breast cancer fuel to grow.

Research has linked excess estrogen to various types of cancers such as the breast, prostate, lung, cervical, uterine, lung, prostate and colorectal cancers. With the aromatase inhibitors the production of estrogen hormone is stopped. The aromatase inhibitors do not stop the production of estrogen hormone at the ovary and therefore they work only at post menopausal stage. As known the ovaries stops producing estrogen hormones after menopause and this may often lead to hormonal imbalance between the estrogen and progesterone hormones which is also known to cause cancer.

The dangers of excess estrogen in the body has been emphasized by oncologists who have advised women to maintain an ideal weight and shed extra fats as Enzyme, aromatase is found in fats, it converts the testosterone into estrogen hormones. The dominance of estrogen in the breasts tissues exposes you to breast cancer. The dangers of estrogen dominance are a lot and so it should be controlled. Let’s look at the implications of excess estrogen hormones.

Dangers of Excess estrogen

Cancer has been linked to estrogen dominance in the body. In a case where estrogen is excessively higher than the progesterone hormones in the body the hormonal environment in the body becomes conducive for the growth of cancer cells. Excess Estrogen hormones in the breast tissues are a major risk to breast cancer.

An imbalance between the progesterone and estrogen hormones is a major cause of cancer. The level of progesterone is always lowered during perimenopause and menopause stages as ovarian hormone production stops completely. When production of this hormone is reduced, the body will have high estrogen hormones hence exposing women to cancer. A key approach to cancer prevention is in ensuring a balance between the estrogen and progesterone hormone is achieved.

Artificial hormone xenoestrogen adds the estrogen activities in our bodies. We get this hormone in commercial dairy products that are from animals injected with growth hormones and it acts as estrogen in our bodies. It is also available in pesticides used to spray crops and unfortunately they end up in our bodies. When introduced in the body they inhabit fatty tissues like the breast tissues and hence favor growth of cancerous cells in the breast. This hormone is more poisonous than natural ‘estrogen dominance’ and it also poisons the DNA, unfortunately xenoestrogen cannot be easily removed from the body.

Some of the drugs that are known to function as estrogen inhibitors are;

I. Arimidex also known as anastrozole

II. Aromasin also known as exemestane

III. Femara also known as letrozole

Each is a pill, usually taken once a day. All three are available as generic medicines.

Benefits of aromatase inhibitors

Aromatase inhibitors have been endorsed by researchers and cancer patients for use in treatment of various types of cancers. In a research study doctors compared the use of aromatase inhibitors and Tamoxifen to see which type of medicine was effective in treating cancer especially the early stage hormone receptor positive breast cancer in post menopausal women. The findings from this study favoured aromatase inhibitors and therefore the doctors recommended the use of aromatase inhibitors after initial treatment that is mostly through conventional cancer therapies like surgery, chemotherapy and radiation therapy.

An aromatase inhibitor is the best hormonal therapy to start with. When treating Doctors have found that aromatase inhibitors are the best hormonal therapy. It was found that treating early-stage, hormone-receptor-positive breast cancer. This is because aromatase inhibitors have more benefits and has fewer side effects than tamoxifen.

Researchers have also proved that when a patient who has been on a tamoxifen for 2 to 3 years switches to aromatase inhibitors for a total of five years, he would benefit more than a patient who has been on five years of Tamoxifen.

The doctors have also recommended the use of aromatase inhibitors for another five years after a patient has been on Tamoxifen for initial five years. This will help the cancer patient to reduce the chances of cancer re-occurring. Therefore it should be taken even after treatment with Tamoxifen.

Some of the side effects of aromatase inhibitors

Researchers have shown that aromatase inhibitors tend to cause fewer side effects as compared to Tamoxifen. However aromatase inhibitors can also cause such side effects as blood clots, stroke, endometrial cancer, heart problems and osteoporosis. It may also cause more broken bones than Tamoxifen. It is therefore important to have a bone density test before you begin using the aromatase inhibitors. The doctors will advice you depending on the bone density test results whether to use bone strengthening medicine in the course of the aromatase inhibitor treatment.

Another common side effect of using Aromatase inhibitors is joint pains. However many people are not troubled with the joint pains after a 2008 British study revealed that women who experienced joint pains while under hormonal therapy medications were less likely to experience the coming back of the disease.

Dr. Dalal Akoury (MD) is an experienced integrative cancer doctor that has helped many cancer patients in their fight against the disease. She has worked hard not only in treating the disease but also in availing informational support to cancer patients at Awaremed which has become a place called home for many cancer patients. Call on her now and get help on cancer.

Aromatase Inhibitors Are Effective In Fighting Cancer

Angiogenesis Inhibitors and Cancer

August 15, 2014

Angiogenesis Inhibitors Play A Great Role In Cancer Treatment

Angiogenesis Metastatic static cancer is a fear of every cancer patient. Metastasis makes it hard for cancer to be treated. However cancer cannot metastasize without angiogenesis which is the sprouting of new blood vessels. The oncologists can best avoid metastasis by avoiding angiogenesis which is only achieved by use of angiogenesis inhibitors.

Angiogenesis defined

Angiogenesis is a process through which blood vessels are formed. Angiogenesis occurs naturally during the growth and development of children. The mother’s womb has to form new blood vessels that are important in the development of the infant. This is a crucial process in the foetus. However in adults this process happens less often and may happen during wound healing. In women it happens during the menstruation cycle. When this formation of new blood vessels is induced by tumor, it is referred to as tumor angiogenesis. This happens when the tumors release molecules that signal the surrounding tissues. It is this signaling that activates genes that make proteins to initiate growth of new blood vessels. These new blood vessels penetrate into the cancerous cells and help them grow by supplying them with the needed nutrients and removing wastes out of them hence creating an environment that favors their growth and metastasis.

Without angiogenesis tumors cannot grow and metastasize, it is therefore a necessity without which the cancerous cells will become inactive and will even die. When the new blood vessels have been formed it become hard for the cancer to be treated. The cancer patient will have to endure pain as the tumors will be growing at a faster rate since they have adequate nutrient supplies which they receive though these newly formed blood vessels therefore they can be controlled when these nutrient supplies are cut and that is what angiogenesis inhibitors does.

This discovery that cancer cells depend on angiogenesis to grow and metastasize has led to development of many cancer treatments that target angiogenesis. These therapies can be very effective in fighting this disease since it doesn’t affect the healthy body cells. Moreover if angiogenesis can be inhibited then all cancers can be controlled since it is a necessity for growth of tumors in all cancers. When angiogenesis is inhibited the cancer cells are denied of their supplies and they will automatically die of starvation.

Copper is a necessity for Angiogenesis

Copper is a trace element the needs to highly regulated as any slight homeostatic copper disruptions may result in serious health complications such as the Wilson’s disease. Copper is necessity for angiogenesis. Without copper angiogenesis cannot take place. It is therefore evident that Copper fuels cancer tumor growth and metastasis. Angiogenetic inhibitors can be used to curb this situation. Tetrathiomolybdate (TM) is effective in copper chelation. Researchers have proved that TM forms a stable tripartite complex with copper and protein. When given with food, it chelates food copper with food protein and inhibits absorption of copper in the bloodstream. There is endogenous secretion of copper in saliva and gastric secretions associated with food intake, and this copper is also chelated by TM when it is taken with meals, thereby preventing copper re-absorption.

Medical researchers have done test on the effectiveness of the tetrathiomolybdate (TM) on mice that were injected with cancer cells and left for a week for angiogenesis to begin. After the new blood vessels had been formed the mice was injected tetrathiomolybdate (TM). The angiogenesis stopped and the tumor growth stopped. However from researches that had been done in the past it was concluded that tetrathiomolybdate (TM) has a unique action on the copper that fuels angiogenesis and retarded tumor growth with minimal side effects. When cancer patients are given TM with food they get a negative copper balance which is not good angiogenesis. The copper that is bound by TM cannot do any meaningful biological activity as it cannot be absorbed by cells and is excreted in the urine having been cleared by bile hence tamed.

Normally, the level of copper that is needed for angiogenesis is much higher as compared to the amount of copper that is needed for cellular activities that are dependent on cancer like cytochrome function and heme synthesis. Cancer therapy that are based on anti-copper may work well as the copper needed for cellular activities will be retained even when TM is used to as an anti-copper angiogenic agent.

Low molecular weight heparins inhibits metastasis

Angiogenesis It has also been found out that Low molecular weight heparins helps in improving the cancer patient’s chances of survival as it inhibits metastasis. The low molecular weight heparins are able to inhibit metastasis by preventing cancer cell triggered destruction of the endothelial glycocalyx. In experimental animal models and clinical tests; it was found that the low molecular weight heparins protects against cancer progression and metastasis. The scientists say this is possible as the low molecular weight inhibits metastasis interfering with the cancer cell binding on the platelets. Cancer cell needs to attach themselves to the platelets to move to other parts of the body. Low molecular weight heparins also inhibit metastasis through binding of heparanase or hyaluronidase thereby protecting the vascular endothelium from invasion by the cancer cells.
Dr. Dalal Akoury (MD) is an experienced integrative cancer doctor that has helped many cancer patients in their fight against the disease. She has worked hard not only in treating the disease but also in availing informational support to cancer patients at Awaremed which has become a place called home for many cancer patients. Call on her now and get help on cancer.

Angiogenesis Inhibitors Play A Great Role In Cancer Treatment

Newly Discovered Protein Inhibits Cancer Growth
Tracon partners on eye drug
New combination drug controls tumor growth and metastasis in mice
Copper Depletion Therapy Keeps High-Risk Triple-Negative Breast Cancer At Bay
Angiogenesis and Metastasis
New Findings on Heparin Therapy from University of Ulsan Summarized (Oral delivery of a potent anti-angiogenic heparin conjugate by chemical…

Gene Therapy, Epigenetic Gene Therapy

August 14, 2014

Gene Therapy Is an Effective Cancer Treatment Alternative

Gene Therapy Cancer has continued to threaten the very existence of the human race. Being a disease with numerous causes, it has become so hard to evade it completely. This has led to doctors trying to find the best ways of curbing it or better yet do away with it completely. Researchers have given foundations upon which these alternative cancer treatments can be based. The researchers have even studied and known the cancer cell survival mechanisms and this has led to emergency of very many alternatives that all affect the cancer cell survival in a way. Just like farmers know-the best way to do away with a weed is to uproot it completely as it will not grow again lest another seed is planted. The best way to treat cancer is to find a way of doing away with it from the roots. Unfortunately most of the cancer treatments that our loved ones are subjected to are only focused on killing the cancer cell and reducing the severity of the symptoms. This is why there are cases of repeated chemotherapies that instead of helping in killing the cancerous cells only make the cancerous cells more resistant to the drugs. Our environments expose us to myriads of carcinogens that affect the DNA make up of our body cells. There are very dangerous heavy metals that will make us prone to cancer when we interact with them consistently and this is a problem that has been facing industrial workers over the years. Upon intrusion into the body they are likely to affect our DNA make up resulting in gene mutation which is synonymous to cancer. Genes play an important role in cancer treatment and so therapies that target the gene may go a long way in healing the cancer patients, that is Gene Therap

Changes that take place in a gene are most likely to cause cancer .these changes that take place in a gene that increases cancer risk may happen due to exposure to environmental carcinogens like smoking tobacco and other potential gene mutants that emanate from the surrounding. However a person may inherit faulty genes from the parents making him have a higher risk of getting cancer. A person may inherit faulty genes from the parent but if he adopts a healthy lifestyle and evade all the potential gene mutants then he may not get the disease.

What is gene therapy?

Cancer being caused by gene mutations it is better to have a way of treating the cancer by repairing the faulty genes or better yet replacing them with functional genes so that the routine gene functions are revived. Gene therapy is a way of repairing genetic problems. This can be achieved by adding a functional copy of the defective gene. When a functional copy of a faulty gene is added, the tissues and organs that might have been affected by the gene mutations will begin to function in the right way. The gene therapy works better because unlike other cancer treatments that only treat the symptoms it goes deeper correcting all the genetic problems.

In cancer treatment most commonly, gene therapy uses a vector, typically a virus, to deliver a gene to the mutated cells where it’s needed to enable proper functions of the cell. Once its inside, the cell’s gene-reading machinery uses the information in the gene to build RNA and protein molecules. The proteins (or RNA) can then carry out their job in the cells. When the normal functioning of the genes is achieved the cancer cell duplication is inhibited and this is a better strategy in cancer treatment.

Scientists are still developing several gene-therapies that will be very helpful in cancer treatment. One of the best therapies so far discovered is the use of a modified version of herpes simplex 1 virus. Herpes simplex 1 virus is known to cause cold sores yet it has been found to have the ability to effectively fight cancer especially the cancer of the skin (melanoma) that has spread in the body.

To make the use of herpes simplex 1 virus safer, the doctors will modify the virus in such a way that it will not cause the cold sores that it is known for. This treatment is referred to T- VEC. This treatment is also safer than other conventional cancer treatments as it does not affect the healthy body cells but is very effective in destroying the cancer cells. It stimulates the immune system enabling it to spot the cancer cells present in the body and fighting them. When the virus is injected into the tumor it produces more of itself by replication inside the tumor until they burst thereby producing even more of them that can infect many more cancer cells.

In a trial to show the effectiveness of the gene therapy, 59 patients suffering from the cancer of the blood had their immune systems cells removed and treated with a virus that genetically altered their genetic structure in order to spot the proteins that covers the surfaces of the cancer cells. The immune cells were then returned into the patient’s body. More than half of the patients experienced complete remission giving proof to the strength of the gene therapy in cancer treatment.

Dr. Dalal Akoury (MD) is an experienced integrative cancer doctor that has helped many cancer patients in their fight against the disease. She has worked hard not only in treating the disease but also in availing informational support to cancer patients at Awaremed which has become a place called home for many cancer patients. Call on her now and get help on cancer.

Gene Therapy Is an Effective Cancer Treatment Alternative

Category Archives: Heavy Metal Toxicit